Skip to NavigationSkip to content

News

The decision was made off the back of Phase 2 and 3 data drawn from 3,500 patients in which Jyseleca was shown to successfully halt the progression...
The product, known as INNA-051, is a synthetic small molecule therapy, self-administered once or twice weekly with an almost immediate effect.
The FDA has announced its approval of GlaxoSmithKline’s Nucala (mepolizumab) as a treatment for hypereosinophilic syndrome (HES).
UK Prime Minister Boris Johnson has announced in a speech to the UN General Assembly that the UK is set to give £500 million to a new global vaccine...
The FDA has released a warning following cases of teens filming themselves overdosing on the antihistamine Benadryl and uploading the videos to...
The approval relates to patients for whom conventional therapies for the prevention of structural joint damage have not been effective.
Under the terms of the agreement, the EU will also have the option to provide a proportion of the reserved doses to low and middle-income nations.
President Trump has outlined his “America First Health Plan” on Thursday, which will allow the easy importation of prescription drugs from Canada.
British consumers have increasingly turned to community pharmacies during the coronavirus pandemic, according to a new study.
The top 10 news stories this week focus on coronavirus vaccine trials, as around one in seven patients who have received Russia’s vaccine against...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches